Sample Solution

  The government is concerned about patients getting freebies because they can potentially lead to larger healthcare costs in the long run. Freebies may be attractive to patients, but they are often given by pharmaceutical or medical device companies with a goal of increasing sales. For example, if a patient receives a free sample of an expensive drug, he or she may be more likely to purchase that same drug in the future (even if it’s not the best for them). If this happens, it could drive up overall healthcare costs as more people buy higher-priced drugs and treatments.

In addition, some freebies have been found to have questionable value when it comes to helping treat patients’ health problems. For instance, many physicians receive gifts from companies whose products they use on their patients without taking into account how beneficial these products really are for the patient. As such, there is potential for overprescribing or using unnecessary medications or treatments due to receiving incentives through freebies rather than making decisions based solely on what is medically necessary for the individual patient. This can lead to additional costs related to treating those unnecessary illnesses and conditions down the line. The government might allow certain types of freebies under certain circumstances in order to protect both consumers and providers from wasteful spending and possible fraud/abuse of resources. In particular, samples that are therapeutically relevant – meaning only one dose per patient visit – could help reduce prescription expenses while ensuring that only necessary products are used on patients in need of treatment. Additionally, any gifts should be reviewed by ethics boards prior to being approved for distribution so that no unethical practices arise from providing these items at no cost. On the other hand, there may also be times when it is in the government's best interest prohibit such gifts altogether; particularly those provided via corporate sponsorships (eg., company-sponsored dinners or trips) which can create conflicts of interests among physicians and their prescribing habits relating back to potentially increased healthcare costs down the line. Ideally though any restrictions put into place should focus on limiting wastefulness rather than prohibiting all forms of gifting completely since research has shown that small token gifts such as flowers or chocolates sent directly from suppliers do not increase prescription costs significantly enough where preventing them would result in significant savings overall within healthcare systems around world..